Infectologia
Covid-19: qual é a evidência para o uso do antiviral Paxlovid?
29 Abr, 2022 | 15:16hCovid-19: What is the evidence for the antiviral Paxlovid? – The BMJ
Conteúdos relacionados:
Yes, Relapses After Paxlovid Happen — Now What? – HIV and ID Observations
A living WHO guideline on drugs for covid-19 – The BMJ
Análise Rasch | Desenvolvimento e validação do questionário de impacto dos sintomas para Covid longa (symptom burden questionnaire for long covid – SBQ-LC).
29 Abr, 2022 | 15:15h
Comentário no Twitter
New research developed and validated a symptom burden questionnaire for long covid which has the potential to benefit international clinical trials and inform clinical management https://t.co/akrRleap0W
— The BMJ (@bmj_latest) April 27, 2022
Estudo observacional | Impacto das vacinas contra Covid-19 na saúde pública dos EUA.
29 Abr, 2022 | 15:13hPublic health impact of covid-19 vaccines in the US: observational study – The BMJ
Editorial: The benefits of large scale covid-19 vaccination – The BMJ
Comentário no Twitter (fio – clique para saber mais)
Paper and accompanying editorial https://t.co/uwqY0PqYsE
"Many more lives could have been saved……
this new study is another confidence booster for covid-19 vaccines." pic.twitter.com/o4FygrAX8T— Eric Topol (@EricTopol) April 27, 2022
Especialistas temem que os EUA padronizem o reforço anual de vacinas contra Covid sem dados suficientes.
29 Abr, 2022 | 15:11hExperts fear U.S. may default to annual Covid boosters without sufficient data – STAT
Comentário no Twitter
Vaccine experts are concerned the U.S. may be sleepwalking into a policy of recommending annual Covid-19 vaccine boosters — without having generated the evidence to show they are actually needed. https://t.co/3TiNZvP0HY
— STAT (@statnews) April 26, 2022
Estudo de fase 2b | Imunização contra o vírus sincicial respiratório durante a gestação.
29 Abr, 2022 | 14:53hPrefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: RSV Prefusion F Protein-Based Immunization Studied in Pregnancy – HealthDay
Comentário no Twitter
In pregnant women, RSVpreF vaccine elicited neutralizing antibody responses with efficient transplacental transfer and without evident safety concerns. https://t.co/r8oktZmBZQ pic.twitter.com/UE7ffxYJW6
— NEJM (@NEJM) April 27, 2022
M-A | Fatores de risco para pneumonia adquirida por Stenotrophomonas maltophilia na UTI.
29 Abr, 2022 | 14:44hRevisão clínica | Diagnóstico e tratamento da Covid-19 na gestação.
28 Abr, 2022 | 12:15hDiagnosis and management of covid-19 in pregnancy – The BMJ
Relatório | Investigação de casos de hepatite aguda de etiologia desconhecida em crianças na Inglaterra.
28 Abr, 2022 | 12:10hConteúdos relacionados:
Multi-Country – Acute, severe hepatitis of unknown origin in children – World Health Organization
WHO says 12 countries have reported unusual cases of hepatitis in kids – STAT
Could Mysterious Hepatitis Cases be Triggered by COVID-19? – Health Policy Watch
U.S., U.K. investigating unusual cases of hepatitis in young children – STAT
Mysterious liver illness seen in kids in US, Europe – Associated Press
Comentário no Twitter
A comprehensive technical report is now available on the cases of hepatitis in young children
Leading hypothesis still Adenovirus, often only positive in blood
Of note, in cases where transplant was required virus levels were 12x higher than other caseshttps://t.co/VMk1qoIyNb
— Alasdair Munro (@apsmunro) April 26, 2022
Estudo de coorte | Incidência da síndrome de Guillain-Barré após vacinação contra Covid-19.
28 Abr, 2022 | 12:07h
Comentário no Twitter
This cohort study of #COVID19 vaccine safety surveillance in the US Vaccine Safety Datalink found a small elevated risk of Guillain-Barré syndrome after Janssen/J&J vaccine but not after mRNA COVID-19 vaccines. @KPDOR https://t.co/TTya5BDqeV
— JAMA Network Open (@JAMANetworkOpen) April 26, 2022